OPS — Opsens Income Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousSmall Cap
- CA$334.82m
- CA$325.92m
- CA$48.35m
Annual income statement for Opsens, fiscal year end - August 31st, CAD millions except per share, conversion factor applied.
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 32.8 | 29.5 | 34.5 | 35.3 | 48.3 |
| Cost of Revenue | |||||
| Gross Profit | 18.7 | 15.6 | 18.7 | 17.8 | 28 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 34.7 | 32.1 | 35.6 | 46.7 | 60.5 |
| Operating Profit | -1.95 | -2.64 | -1.13 | -11.3 | -12.1 |
| Net Income Before Taxes | -1.95 | -2.64 | -1.13 | -11.3 | -12.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.95 | -2.64 | -1.15 | -11.4 | -12.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.95 | -2.64 | -1.15 | -11.4 | -12.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.95 | -2.64 | -1.15 | -11.4 | -12.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.022 | -0.048 | -0.017 | -0.105 | -0.11 |